Triochem Products (BOM:512101) Days Payable: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Triochem Products Days Payable?

Triochem Products BOM:512101 Days Payable is 0.00 as of Mar. 2026.

Triochem Products's average Accounts Payable for the three months ended in Mar. 2026 was ₹0.30 Mil. Triochem Products's Cost of Goods Sold for the three months ended in Mar. 2026 was ₹0.00 Mil.

The historical rank and industry rank for Triochem Products's Days Payable or its related term are showing as below:

During the past 13 years, Triochem Products's highest Days Payable was 575970.00. The lowest was 14.22. And the median was 19.18.

BOM:512101's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.38
* Ranked among companies with meaningful Days Payable only.

Triochem Products's Days Payable declined from Mar. 2025 (267.37) to Mar. 2026 (0.00). It may suggest that Triochem Products accelerated paying its suppliers.

Triochem Products Days Payable Historical Data

* Premium members only.

The historical data trend for Triochem Products's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Triochem Products Days Payable Chart

Triochem Products Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.36 0.00 575,970.00 985.64 0.00

Triochem Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 267.37 0.00 0.00 0.00 0.00

BOM:512101 vs GOVX, MBVXQ, HSTC: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Triochem Products's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Triochem Products Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Triochem Products's Days Payable distribution charts can be found below:

* The bar in red indicates where Triochem Products's Days Payable falls into.


Triochem Products Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Triochem Products's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as

Days Payable (A: Mar. 2026 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2025 ) + Accounts Payable (A: Mar. 2026 )) / count ) / Cost of Goods Sold (A: Mar. 2026 )*Days in Period
=( (1.55 + 0.295) / 2 ) / 0*365
=0.9225 / 0*365
=N/A

Triochem Products's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0 + 0.295) / 1 ) / 0*365 / 4
=0.295 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Triochem Products (BOM:512101) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Triochem Products and its competitors. Over the past decade, Triochem Products' Days Payable has ranged from 14.22 to 575,970.00.
Is Triochem Products' Days Payable too high?
Triochem Products' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 14.22 to a high of 575,970.00.
How does Triochem Products' Days Payable compare to GOVX and MBVXQ?
Triochem Products' Days Payable of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.38. Historically, Triochem Products' own Days Payable has ranged from 14.22 to 575,970.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Triochem Products and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Triochem Products's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Triochem Products stock overvalued right now?
Triochem Products (BOM:512101) has a current Days Payable of 0.00. The stock's GF Value™ is ₹10.79, compared to a current price of ₹17.40 — trading 61.3% above its estimated fair value. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Triochem Products (BOM:512101), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Triochem Products Business Description

Address Sir P. M. Road, Sambava Chambers, 4th Floor, Fort, Mumbai, MH, IND, 400 001
Triochem Products Ltd is an India-based pharmaceutical company. It is engaged in manufacturing and exporting of pharmaceutical bulk drugs, active pharmaceutical ingredients, and chemicals. The company's product range includes iodine compounds, citrates, and piperazine salts. Its key markets are Europe, America, and South-East Asia.